INDUSTRY RESEARCH

Market intelligence across pharma, MedTech, and digital health.

3,460+ published studies covering therapeutics, diagnostics, devices, and healthcare services — sized bottom-up and top-down, validated by our dedicated Healthcare & Medical Devices research team, and delivered with country-level detail.

3,460+ Published studies
9 Sub-domains tracked
100+ Countries covered
Weekly New titles added
Our expertise in this vertical

The Healthcare & Medical Devices Research Team

This vertical is covered by a dedicated research group inside Fundamental Business Insights that tracks the global healthcare and medical technology industry full-time. Our analysts follow clinical adoption trends, regulatory developments, reimbursement policy, healthcare infrastructure investment, and evolving patient-care requirements as they happen — not just at the point a report is commissioned.

Every estimate in this vertical is built from primary conversations with healthcare stakeholders and cross-checked against company financial disclosures, regulatory publications, clinical literature, and government health databases, then reconciled through both bottom-up and top-down modeling before an internal quality review.

HC Reports in this section are prepared and reviewed by the Healthcare & Medical Devices research team.

Who we interview

Clinical KOLs, regulatory affairs heads, hospital procurement leads, and MedTech product & commercial teams.

Regulatory fluency

Analysts track FDA, EMA, and regional approval pathways so device and drug forecasts reflect real timelines.

Reimbursement modeling

Forecasts factor in payer policy and reimbursement shifts, not just clinical or technology adoption curves.

Coverage within this vertical

Sub-domains we track

Healthcare & Medical Devices reports on this site span the following sub-domains. Reports aren't filed under these as separate sub-categories yet — search or browse the full list below to find a specific market.

01

Pharmaceuticals

Small-molecule and branded/generic drug markets across therapeutic areas and dosage forms.

02

Biotechnology & Advanced Therapies

Cell and gene therapies, biologics, and next-generation biotech platforms.

03

Medical Devices

Diagnostic, surgical, monitoring, and implantable device categories across care settings.

04

Medical Diagnostics

In-vitro diagnostics, imaging, and point-of-care testing markets.

05

Analytical & Laboratory Technologies

Lab instrumentation, reagents, and analytical platforms used in research and clinical settings.

06

Healthcare IT & Digital Health

EHR platforms, telehealth, remote monitoring, and clinical software markets.

07

Clinical & Healthcare Services

Hospital operations, outpatient care, and healthcare service delivery models.

08

Veterinary Healthcare

Animal health diagnostics, pharmaceuticals, and veterinary device markets.

09

Life Science Research Tools

Instruments, reagents, and platforms supporting pharmaceutical and academic research.

These sub-domains describe the breadth of coverage in this vertical — the report list below isn't filterable by sub-domain. Use search or contact us if you're after a specific market.
Research intelligence

Secondary sources behind this vertical

Alongside primary interviews, every Healthcare & Medical Devices estimate is checked against these authoritative public and regulatory sources.

Secondary source Official website
World Health Organization (WHO) who.int ↗
U.S. Food & Drug Administration (FDA) fda.gov ↗
European Medicines Agency (EMA) ema.europa.eu ↗
Centers for Disease Control and Prevention (CDC) cdc.gov ↗
National Institutes of Health (NIH) nih.gov ↗
National Center for Biotechnology Information (NCBI) ncbi.nlm.nih.gov ↗
PubMed pubmed.ncbi.nlm.nih.gov ↗
ClinicalTrials.gov clinicaltrials.gov ↗
International Organization for Standardization (ISO) iso.org ↗
ASTM International astm.org ↗
Advanced Medical Technology Association (AdvaMed) advamed.org ↗
Medical Device Innovation Consortium (MDIC) mdic.org ↗
Biotechnology Innovation Organization (BIO) bio.org ↗
Int'l Federation of Pharmaceutical Manufacturers & Associations (IFPMA) ifpma.org ↗
U.S. Pharmacopeia (USP) usp.org ↗
European Directorate for the Quality of Medicines & HealthCare (EDQM) edqm.eu ↗
World Organisation for Animal Health (WOAH) woah.org ↗
American Hospital Association (AHA) aha.org ↗
OECD Health oecd.org/health ↗
World Bank Data data.worldbank.org ↗
Showing 121 – 130 of 4,607 Industry Research reports
Industry Research Oct 2026

Asthma Drugs Market Size & Share, By Medication (Quick Relief Medications, Long-term Control Medications, Others), Mode of Administration (Tablets and Capsules, Liquids, Inhalers, Injections, and Sprays and Powders), Organization Type (Public, Private), Application (Pediatric, Adults, Adolescent) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

The global asthma drugs market size is projected to grow from USD 25.12 billion in 2024 to USD 40.92 billion by 2034, with a CAGR surpassing 5% throughout the forecast period (2025...

Industry Research Oct 2026

Pharmaceutical Unit-dose Packaging Market Size & Share, By Material (Plastics, Glass, Paper and Paperboard, Metal), Product (Vials, Syringe and cartridge, Ampoules, Blisters), End-use (Ophthalmic, Injectable, Biologics, Wound Care, Respiratory Therapy, Orals) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

The global pharmaceutical unit-dose packaging market size is projected to rise from USD 40.55 billion in 2024 to USD 159.82 billion by 2034, representing a CAGR above 14.7% for the...

Industry Research Oct 2026

Autoinjectors Market Size & Growth Forecast 2027–2036, By Segments (Type, Route of Administration, End-use, Therapy), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Autoinjectors Market size is set to grow from USD 77.31 billion in 2025 to USD 264.77 billion by 2035, reflecting a CAGR greater than 13.1% through 2026-2035. Industry revenues in...

Industry Research Oct 2026

Single-cell Analysis Market Size & Forecasts 2026-2035, By Segments (Product, Workflow, End-use, Application), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (10x Genomics, Fluidigm, Bio-Rad Laboratories, Illumina, Mission Bio)

Single-cell Analysis Market size is anticipated to rise from USD 5.04 billion in 2025 to USD 28.7 billion by 2035, reflecting a CAGR surpassing 19% over the forecast horizon of 202...

Industry Research Oct 2026

Point-of-care Ultrasound Market Size & Share, By Type (Diagnostic, Therapeutic), Portability (Trolley-Based Devices, Handheld Devices), Application (Emergency Medicine, Cardiology, Obstetrics & Gynecology, Urology, Vascular Surgery, Musculoskeletal), End users (Hospitals, Clinics, Maternity Centers, Ambulatory Surgical Centers, Others), Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Point-of-care Ultrasound Market was over USD 4.35 Billion in 2023 and is expected to exceed USD 8.13 Billion by end of the year 2032, observing around 7.2% CAGR between 2024 and 20...

Industry Research Oct 2026

Radiation Therapy Market Size & Share, By Type (Product, Service), Technology (External Beam Radiotherapy, Convnetial Cobalt-60 Teletherapy Units, Particle Therapy Systems, Internal Beam Radiotherapy/Brachytherapy, Systemic Radiotherapy), Application (External Beam Radiotherapy, Internal Beam Radiotherapy/Brachytherapy), Procedure, End-User - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

The global radiation therapy market size is set to grow from USD 8.1 billion in 2024 to USD 18.31 billion by 2034, reflecting a CAGR of more than 8.5% between 2025 and 2034.

Industry Research Oct 2026

Newborn Eye Imaging Systems Market Size & Share, By Disease Type (ROP, Retinal Disease, Strabismus, Refractive Error, Color Blindness, Others), Device Type (Basic Device, Wireless Device), End User (Hospitals, Ophthalmology Diagnosis Centers, Ambulatory Surgical Centers, Others) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

The global newborn eye imaging systems market size is expected to expand from USD 1.75 billion in 2024 to USD 2.99 billion by 2034, demonstrating a CAGR of more than 5.5% between 2...

Industry Research Oct 2026

Influenza Drug Market Size & Share, By Type (Antiviral Medications, Vaccines, Immunomodulators, Symptomatic Treatments, Combination Therapies), Mechanism of Action (Neuraminidase Inhibitors, Cap-dependent Endonuclease Inhibitors, Fusion Inhibitors, M2 Ion Channel Inhibitors, Host Cell Protease Inhibitors, Immunomodulatory Agents, RNA Polymerase Inhibitors, Others), Route of Administration, End user - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

The global influenza drug market size is set to increase from USD 1.09 billion in 2024 to USD 1.38 billion by 2034, with a projected CAGR exceeding 2.4% from 2025 to 2034.

Industry Research Oct 2026

Drug-Eluting Balloon Catheters Market Size & Growth Forecast 2027–2036, By Segments (Product, Material, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Drug-Eluting Balloon Catheters Market size is predicted to expand from USD 682.99 million in 2025 to USD 1.79 billion by 2035, with growth underpinned by a CAGR above 10.1% between...

Need an Industry Research study we haven't published yet?

Our Healthcare team scopes custom studies using the same interview network and validation framework — typically delivered in 2–3 weeks.